Invention Grant
- Patent Title: Nucleic acids encoding anti-CD40 antibodies
-
Application No.: US16946302Application Date: 2020-06-15
-
Publication No.: US11267895B2Publication Date: 2022-03-08
- Inventor: Jacques F. Banchereau , Gerard Zurawski , Sandra Zurawski , SangKon Oh
- Applicant: BAYLOR RESEARCH INSTITUTE
- Applicant Address: US TX Dallas
- Assignee: BAYLOR RESEARCH INSTITUTE
- Current Assignee: BAYLOR RESEARCH INSTITUTE
- Current Assignee Address: US TX Dallas
- Agency: Norton Rose Fulbright US LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K14/005 ; A61K39/00

Abstract:
The present invention includes compositions and methods for the expression, secretion and use of novel compositions for use as, e.g., vaccine and antigen delivery vectors, to delivery antigens to antigen presenting cells. In one embodiment, the vector is an anti-CD40 antibody, or fragments thereof, and one or more antigenic peptides linked to the anti-CD40 antibody or fragments thereof, including humanized antibodies.
Public/Granted literature
- US20210024641A1 ANTI-CD40 ANTIBODIES AND USES THEREOF Public/Granted day:2021-01-28
Information query